{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:51:19Z","timestamp":1790895079566,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.contraception.2011.10.008","type":"journal-article","created":{"date-parts":[[2011,12,9]],"date-time":"2011-12-09T19:29:00Z","timestamp":1323458940000},"page":"527-537","source":"Crossref","is-referenced-by-count":47,"title":["Contraception for individuals with sickle cell disease: a systematic review of the literature"],"prefix":"10.1016","volume":"85","author":[{"given":"Lisa B.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Legardy-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Cwiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.contraception.2011.10.008_bb0005","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2011.10.008_bb0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.10.008_bb0015","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2009.03.010","article-title":"Infection in sickle cell disease: a review","volume":"14","author":"Booth","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.contraception.2011.10.008_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0029-7844(95)00367-3","article-title":"Pregnancy in sickle cell disease: experience of the Cooperative Study of Sickle Cell Disease","volume":"87","author":"Smith","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9378(97)70209-6","article-title":"Women with sickle cell trait are at increased risk for preeclampsia","volume":"177","author":"Larrabee","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-198602000-00012","article-title":"Pregnancy in sickle cell disease","volume":"67","author":"Powars","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0308-2261(21)00502-6","article-title":"Pregnancy in sickle cell disease","volume":"14","author":"Charache","year":"1985","journal-title":"Clin Haematol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0040","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1067\/mob.2001.115477","article-title":"Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia","volume":"184","author":"Sun","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1783\/147118910791749425","article-title":"Oral contraceptives and venous thromboembolism consensus opinion from an international workshop held in Berlin, Germany in December 2009","volume":"36","author":"Reid","year":"2010","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.10.008_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0306-9877(91)90029-X","article-title":"Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications","volume":"35","author":"Francis","year":"1991","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.contraception.2011.10.008_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-199104000-00018","article-title":"Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion","volume":"2","author":"Francis","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.contraception.2011.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3324\/haematol.2009.013672","article-title":"Hypercoagulability and thrombotic complications in hemolytic anemias","volume":"94","author":"Ataga","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.contraception.2011.10.008_bb0065","doi-asserted-by":"crossref","unstructured":"Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006;119:897 e897-811.","DOI":"10.1016\/j.amjmed.2006.08.015"},{"key":"10.1016\/j.contraception.2011.10.008_bb0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1182\/blood-2006-11-057604","article-title":"Sickle cell trait and the risk of venous thromboembolism among blacks","volume":"110","author":"Austin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2011.10.008_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3181\/00379727-124-31768","article-title":"Interaction of progesterone and aldosterone with red blood cells of the rat","volume":"124","author":"DeVenuto","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.contraception.2011.10.008_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1471-0528.1996.tb09716.x","article-title":"The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives","volume":"103","author":"Norris","year":"1996","journal-title":"Br J Obstet Gynaeco"},{"key":"10.1016\/j.contraception.2011.10.008_bb0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.STR.10.4.464","article-title":"Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion","volume":"10","author":"Mehta","year":"1979","journal-title":"Stroke"},{"key":"10.1016\/j.contraception.2011.10.008_bb0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000204519","article-title":"Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis","volume":"89","author":"Papadimitriou","year":"1993","journal-title":"Acta Haematol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0095","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V79.8.2154.2154","article-title":"Red blood cell changes during the evolution of the sickle cell painful crisis","volume":"79","author":"Ballas","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2011.10.008_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-77-3-417","article-title":"Reduced red cell filterability with oral contraceptive agents","volume":"77","author":"Oski","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2011.10.008_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3181\/00379727-150-39037","article-title":"Effect of oral contraceptives and pregnancy on erythrocyte deformability and surface charge","volume":"150","author":"Durocher","year":"1975","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.contraception.2011.10.008_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2257.1998.00027.x","article-title":"The effect of ovarian steroids on sickle cell deformability","volume":"20","author":"Yoong","year":"1998","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0115","doi-asserted-by":"crossref","unstructured":"Isaacs WA. The effect of certain lipid substances on sickling. Acta Haematol;45:259-65.","DOI":"10.1159\/000208633"},{"key":"10.1016\/j.contraception.2011.10.008_bb0120","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(72)90359-5","article-title":"Steroid treatment in the prevention of painful episodes in sickle-cell disease","volume":"1","author":"Isaacs","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.10.008_bb0125","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/2151139a0","article-title":"Steroid hormones in sickle-cell disease","volume":"215","author":"Isaacs","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.contraception.2011.10.008_bb0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.contraception.2005.08.010","article-title":"Progestogen-only contraceptive use among women with sickle cell anemia: a systematic review","volume":"73","author":"Legardy","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.10.008_bb0135","first-page":"CD006261","article-title":"Steroid hormones for contraception in women with sickle cell disease","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.contraception.2011.10.008_bb0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.amepre.2005.02.008","article-title":"Keeping up with evidence a new system for WHO's evidence-based family planning guidance","volume":"28","author":"Mohllajee","year":"2005","journal-title":"Am J Prev Med"},{"issue":"3 Suppl","key":"10.1016\/j.contraception.2011.10.008_bb0145","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0749-3797(01)00261-6","article-title":"Current methods of the US Preventive Services Task Force: a review of the process","volume":"20","author":"Harris","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.contraception.2011.10.008_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.contraception.2010.06.017","article-title":"Hormonal contraception use and pregnancy in adolescents with sickle cell disease: analysis of Michigan Medicaid claims","volume":"83","author":"O'Brien","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.10.008_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"2","author":"De Ceulaer","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.10.008_bb0160","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1136\/bmj.306.6894.1735","article-title":"Contraceptives, counselling, and pregnancy in women with sickle cell disease","volume":"306","author":"Howard","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.10.008_bb0165","first-page":"85","article-title":"Norplant use by women with sickle cell disease","volume":"41","author":"Ladipo","year":"1993","journal-title":"Internl J Gynecol Obstet"},{"key":"10.1016\/j.contraception.2011.10.008_bb0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.10.008_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0009-9236(98)90074-1","article-title":"Nomegestrol acetate contraceptive implant use by women with sickle cell disease","volume":"64","author":"Nascimento Mde","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.contraception.2011.10.008_bb0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1600-0609.2003.00061.x","article-title":"Markers of platelet activation, thrombin generation and fibrinolysis in women with sickle cell disease: effects of differing forms of hormonal contraception","volume":"70","author":"Yoong","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1365-2141.1999.01255.x","article-title":"Red cell deformability in oral contraceptive pill users with sickle cell anaemia","volume":"104","author":"Yoong","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.contraception.2011.10.008_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0010-7824(01)00202-5","article-title":"Carbohydrate metabolism in sickle cell patients using a subdermal implant containing nomegestrol acetate (Uniplant)","volume":"63","author":"Barbosa","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.10.008_bb0195","first-page":"3","article-title":"Contraception and sickle cell disease","volume":"28","author":"Howard","year":"1994","journal-title":"IPPF Med Bull"},{"key":"10.1016\/j.contraception.2011.10.008_bb0200","doi-asserted-by":"crossref","unstructured":"Austin H, Lally C, Benson JM, Whitsett C, Hooper WC, Key NS. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol 2009;200:620 e621-623.","DOI":"10.1016\/j.ajog.2009.01.038"},{"key":"10.1016\/j.contraception.2011.10.008_bb0205","article-title":"U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. Adapted from the World Health Organization Criteria for Contraceptive Use, 4th edition","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Early Release"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411005816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411005816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T16:16:18Z","timestamp":1639930578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411005816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0010782411005816"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.10.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}